Cerus Corp reports results for the quarter ended December 31 - Earnings Summary

• Cerus Corp CERS.OQ reported a quarterly adjusted loss of 1 cent​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -2 cents. The mean expectation of four analysts for the quarter was for a loss of 3 cents per share. Wall Street expected results

• Revenue rose 13.7% to $52.70 million from a year ago; analysts expected $54.40 million.

• Cerus Corp's reported EPS for the quarter was a loss of 1 cent​.

• The company reported a quarterly loss of $19 thousand.

• Cerus Corp shares had risen by 24.3% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

• Wall Street's median 12-month price target for Cerus Corp is $5.00, about 49.4% above its last closing price of $2.53

This summary was machine generated from LSEG data March 2 at 11:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)